Imatinib Mesylate

Company
Business Type
Manufacturer
Country
India
Category

Quick Details

Brand Name: Veenat
Place of Origin: India

Product Detail

We are instrumental in providing our customers Imatinib 100 mg Capsule which is used to treat certain types of cancer (e.g., chronic myeloid leukaemia, gastrointestinal stromal tumours, and myelodysplastic/myeloproliferative diseases). Imatinib works by stopping or slowing the growth of cancer cells (tumours). It also works by causing cancer cells to die and falls in the category of protein tyrosine kinase inhibitor. The these capsules is manufactured by Cipla Pharmaceuticals Ltd India and is available in sizes of 100mg and 400mg. Its dose should only be determined by the doctor as it can produce side effects in lactating and pregnant women. The medicine is available under different names, produced by different companies and we stock those medicines as well.

Similar Products

Veenat

About our Company

Company
Business Type
Manufacturer
Established
2007
Employess
26-100
Annual Revenue
US$5 Million - US$10 Million
Main Markets
South America, South Asia, Middle East
Export Ratio
91% - 100%
Products
Veenat

Regional Suppliers

Veenat in India

Contact Us

Genex Pharma

Mr. Hiral Shah

India

Send us a message